Seeking Alpha has an article on ISIS Pharmaceuticals where the author talks about its two potential blockbuster drugs, specifically obesity-busting diabetic drug ISIS 113715, which normalizes glucose but does not cause hypoglycemia like some oral diabetic agents.
You can read all ISIS posts here.
No comments:
Post a Comment